ロード中...
MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic targets in AD. Previously, using senescence-accelera...
保存先:
| 出版年: | Antioxidants (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8300733/ https://ncbi.nlm.nih.gov/pubmed/34208998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10071058 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|